In today's Morning Rounds newsletter, NIH is finally spending down its coffers, FDA eyes tighter regulations on chatbots for ...

He relayed the message Tuesday at a meeting of health care product makers and Wednesday to an FDA advocacy group. In addition ...

Call it death by disclosure. After nearly 30 years in which prescription drug ads have become a fixture on television, the ...

"The Pitt," nominated for 13 Emmys, ignores the financial consequences of emergency care. The average ED visit costs $750, ...

If Kennedy doesn’t resign, physicians should join a limited strike. Desperate diseases call for desperate measures.

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...

Three scientists who revolutionized the treatment of cystic fibrosis and prolonged the lifespan of patients with the deadly ...

A new liquid biopsy test from Exact Sciences scans for 50 cancers in one blood sample. The company says it marks a new era in ...

The FDA is aiming to reduce reliance on opioids by providing guidance on the development of prescription non-opioid ...

Merck decided to halt research operations in the U.K. and bail on a major London research center, in part to protest how the ...

The FDA will convene experts on Nov. 6 to discuss challenges around regulating mental health products that use artificial ...

On Aug. 20, in Bulape, a small town in the Democratic Republic of Congo’s Kasaï province, a 34-year-old pregnant woman was ...